Provided by Tiger Trade Technology Pte. Ltd.

ADMA Biologics

9.29
-0.1000-1.06%
Volume:791.23K
Turnover:7.37M
Market Cap:2.08B
PE:13.26
High:9.50
Open:9.42
Low:9.20
Close:9.39
52wk High:20.46
52wk Low:7.21
Shares:223.98M
Float Shares:210.51M
Volume Ratio:0.57
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7004
EPS(LYR):0.6000
ROE:41.90%
ROA:21.78%
PB:5.10
PE(LYR):15.48

Loading ...

Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 10, 2024

Major Issues Report

Form 8-K - Current report
Oct 09, 2024

Major Issues Report

Form 8-K - Current report
Sep 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jul 26, 2024

Major Issues Report

Form 8-K - Current report